文献
J-GLOBAL ID:201702288142128742
整理番号:17A1430288
限局期小細胞肺癌(包装印刷/加工における改心)患者における同時1日1回と1日2回化学放射線療法:非盲検,第3相無作為化優越性試験【Powered by NICT】
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
著者 (21件):
Faivre-Finn Corinne
(Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK)
,
Faivre-Finn Corinne
(Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK)
,
Snee Michael
(St James Institute of Oncology, Leeds, UK)
,
Ashcroft Linda
(Manchester Academic Health Science Centre Trials Co-ordination Unit, The Christie NHS Foundation Trust, Manchester, UK)
,
Appel Wiebke
(Rosemere Cancer Centre, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK)
,
Barlesi Fabrice
(Multidisciplinary Oncology & Therapeutic Innovations Department, Aix Marseille Univ, Assistance Publique Hopitaux de Marseille, Marseille, France)
,
Bhatnagar Adityanarayan
(Department of Clinical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK)
,
Bezjak Andrea
(Canadian Cancer Trials Group, Princess Margaret Cancer Center, Toronto, ON, Canada)
,
Cardenal Felipe
(GECP, Department of Medical Oncology, Institut Catala’Oncologia, L’Hospitalet (Barcelona), Barcelona, Spain)
,
Fournel Pierre
(GFPC, Departement d’Oncologie Medicale, Institut de Cancerologie Lucien Neuwirth, Saint-Etienne, France)
,
Harden Susan
(Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK)
,
Le Pechoux Cecile
(Departement d’Oncologie Radiotherapie, Gustave Roussy Cancer Campus, Villejuif, France)
,
McMenemin Rhona
(Northern Centre for Cancer Care, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK)
,
Mohammed Nazia
(Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, UK)
,
O’Brien Mary
(Department of Medicine, Royal Marsden NHS Foundation Trust, Surrey, UK)
,
Pantarotto Jason
(Division of Radiation Oncology, University of Ottawa, Ottawa, ON, Canada)
,
Surmont Veerle
(Department of Respiratory Medicine/Thoracic Oncology, Ghent University Hospital, Ghent, Belgium)
,
Van Meerbeeck Jan P
(Thoracic Oncology, Antwerp University Hospital, Antwerp, Belgium)
,
Woll Penella J
(Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK)
,
Lorigan Paul
(Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK)
,
Blackhall Fiona
(Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
18
号:
8
ページ:
1116-1125
発行年:
2017年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)